Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2008-A00233-52 | Other Identifier | ANSM | |
| DGS2008-0193 | Other Identifier | DGOS |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Groupe de Recherche sur la Thrombose | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pregnancy complications called PVP are mainly responsible for perinatal mortality. In these cases, the placenta is smaller and often the centre of thrombotic lesions. The estimation of the placenta volume by 3D ultrasound coupled with growth factors and D-Dimers measures could improve the understanding of these pathologies to optimize their detection.
Pregnancy complications called Placental Vascular Pathologies (PVP) are mainly responsible for perinatal mortality. In these cases, the placenta is smaller and often the centre of thrombotic lesions. The estimation of the placenta volume by 3D ultrasound coupled with growth factors and D-Dimers measures could improve the understanding of these pathologies to optimize their detection. Thus, the identification of predictive factors of the risk of occurrence or recurrence of PVP could allow us to propose a monitoring of patients at risk, to anticipate corticoids administration for the foetuses pulmonary maturation and perhaps later to adapt anti hypertensive and antithrombotic therapeutics.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pregnant patients with VPP antecedent | Pregnancy women consulting for an scan during their 12th week of amenorrhea at the University Hospital of Saint Etienne will be studied in this clinical trial. They have an history of VPP (Vascular Placental Pathology). They will have to give a blood sample. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood sample | Other | biological markers evaluated : D-Dimer, sEPCR |
|
| Measure | Description | Time Frame |
|---|---|---|
| placental volume by 3D ultrasound and D-Dimers rate | Week 12 |
| Measure | Description | Time Frame |
|---|---|---|
| EPCRs rate measurements | Week 12 | |
| EPCRs rate measurements | Week 16 | |
| EPCRs rate measurements |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
community sample
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Céline CHAULEUR, MD | CHU de Saint-Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service de Gynécologie Obstétrique - CHU Saint-Etienne | Saint-Etienne | 42055 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| D004461 | Eclampsia |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
plasma and serum samples
| Week 22 |
| Occurrence or recurrence of PVP | Week 12 |
| Occurrence or recurrence of PVP | Week 16 |
| Occurrence or recurrence of PVP | Week 22 |
| placental volume by 3D ultrasound and D-Dimers rate | Week 16 |
| placental volume by 3D ultrasound and D-Dimers rate | Week 22 |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |